{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:14:23Z","timestamp":1779718463858,"version":"3.53.1"},"reference-count":23,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Guttate psoriasis is often precipitated by strepto-coccal infections and is generally regarded as a mild subtype of psoriasis; however, its potential associations with systemic comorbidities are insufficiently explored. In this study, we aimed to evaluate the association of guttate psoriasis with systemic comorbidities such as metabolic syndrome and psoriatic arthritis and identify factors affecting recurrence. In this retrospective single-centercentre study, we reviewed the data of patients with the first eruption of guttate psoriasis between 1998 and 2020 and at least 4 years of follow-up data. Demographic information and medical data (type of treatment, psoriasis flare-ups, remission of disease, and development of metabolic syndrome and\/or psoriatic arthritis) were retrieved. Of 395 patients included (mean follow up, 83\u00b134.7 months), 34.9 % experienced at least one recurrence, 14.68 % had multiple recurrences, 5.6 % developed psoriatic arthritis, and 8.6 % had metabolic syndrome. Male sex, topical treatment and residual disease were significant risk factors for recurrence. Psoriatic arthritis was strongly associated with multiple recurrences, while a possible association with metabolic syndrome was observed, highlighting the importance of careful long-term monitoring in this population.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0112","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:37:20Z","timestamp":1779716240000},"source":"Crossref","is-referenced-by-count":0,"title":["From Onset to Outcome: A Long-term Retrospective, Single centre Study of Guttate Psoriasis from Israel"],"prefix":"10.2340","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2964-7417","authenticated-orcid":false,"given":"Riad","family":"Kassem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofar","family":"Edri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Galili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lyakhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Tzanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Pavlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"156501","doi-asserted-by":"crossref","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nat Rev Dis Primers 2016; 2: 16082.","DOI":"10.1038\/nrdp.2016.82"},{"key":"156502","doi-asserted-by":"crossref","unstructured":"Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 Suppl 2: ii18\u201323.","DOI":"10.1136\/ard.2004.033217"},{"key":"156503","unstructured":"Gudjonsson JE, Elder JT. Psoriasis. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al, editors. Fitzpatrick\u2019s Dermatology, 9e McGraw Hill Medical. New York: McGraw-Hill Education; 2019. [cited 2021 October 1]."},{"key":"156504","doi-asserted-by":"crossref","unstructured":"Rajguru JP, Maya D, Kumar D, Suri P, Bhardwaj S, Patel ND. Update on psoriasis: a review. J Family Med Prim Care 2020; 9: 20\u201324.","DOI":"10.4103\/jfmpc.jfmpc_689_19"},{"key":"156505","doi-asserted-by":"crossref","unstructured":"Fargnoli MC, De Simone C, Gisondi P, Pellacani G, Calzavara-Pinton P. Topical treatment for the management of mild-to-moderate psoriasis: a critical appraisal of the current literature. Dermatol Ther 2023; 13: 2527\u20132547.","DOI":"10.1007\/s13555-023-01024-9"},{"key":"156506","doi-asserted-by":"crossref","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med 2021; 21: 170\u2013173.","DOI":"10.7861\/clinmed.2021-0257"},{"key":"156507","doi-asserted-by":"crossref","unstructured":"Zhou S, Yao Z. Roles of infection in psoriasis. Int J Mol Sci 2022; 23: 6955.","DOI":"10.3390\/ijms23136955"},{"key":"156508","doi-asserted-by":"crossref","unstructured":"Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106\u20132112.","DOI":"10.1172\/JCI118263"},{"key":"156509","doi-asserted-by":"crossref","unstructured":"Sato H, Ishikawa H. Unspecific increase of antistreptolysin-O titer in acute guttate psoriasis. J Dermatol 1977; 4: 187\u2013191.","DOI":"10.1111\/j.1346-8138.1977.tb01036.x"},{"key":"156510","unstructured":"Saleh D, Tanner LS. Guttate psoriasis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021."},{"key":"156511","doi-asserted-by":"crossref","unstructured":"Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM, Atlas GP. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol 2021; 184: 243\u2013258.","DOI":"10.1111\/bjd.19169"},{"key":"156512","doi-asserted-by":"crossref","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 2017; 76: 377\u2013390.","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"156513","doi-asserted-by":"crossref","unstructured":"Gisondi P, Fostini AC, Foss\u00e0 I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol 2018; 36: 21\u201328.","DOI":"10.1016\/j.clindermatol.2017.09.005"},{"key":"156514","doi-asserted-by":"crossref","unstructured":"Wu JJ, Choi YM, Bebchuk JD. Risk of myocardial infarction in psoriasis patients: a retrospective cohort study. J Dermatolog Treat 2015; 26: 230\u2013234.","DOI":"10.3109\/09546634.2014.952609"},{"key":"156515","doi-asserted-by":"crossref","unstructured":"Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 2019; 80: 251\u2013265.","DOI":"10.1016\/j.jaad.2018.06.027"},{"key":"156516","doi-asserted-by":"crossref","unstructured":"Lindberg I, Lilja M, Geale K, Tian H, Richardson C, Scott A, et al. Incidence of psoriatic arthritis in patients with skin psoriasis and associated risk factors: a retrospective population-based cohort study in Swedish routine clinical care. Acta Derm Venereol 2020; 100: adv00324.","DOI":"10.2340\/00015555-3682"},{"key":"156517","doi-asserted-by":"crossref","unstructured":"Svedbom A, Mallbris L, Larsson P, Nikamo P, Wolk K, Kjellman P, et al. Long-term outcomes and prognosis in new-onset psoriasis. JAMA Dermatol 2021; 157: 1\u20138.","DOI":"10.1001\/jamadermatol.2021.0734"},{"key":"156518","doi-asserted-by":"crossref","unstructured":"Naldi L, Peli L, Parazzini F, Carrel CF, Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol 2001; 44: 433\u2013438.","DOI":"10.1067\/mjd.2001.110876"},{"key":"156519","doi-asserted-by":"crossref","unstructured":"Ko HC, Jwa SW, Song M, Kim MB, Kwon KS. Clinical course of guttate psoriasis: long-term follow-up study. J Dermatol 2010; 37: 894\u2013899.","DOI":"10.1111\/j.1346-8138.2010.00871.x"},{"key":"156520","doi-asserted-by":"crossref","unstructured":"Martin BA, Chalmers RJ, Telfer NR. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol 1996; 132: 717\u2013718.","DOI":"10.1001\/archderm.1996.03890300147032"},{"key":"156521","unstructured":"Pfingstler LF, Maroon M, Mowad C. Guttate psoriasis outcomes. Cutis 2016; 97: 140\u2013144."},{"key":"156522","doi-asserted-by":"crossref","unstructured":"Galili E, Levy SR, Tzanani I, Segal O, Lyakhovitsky A, Barzilai A, et al. New-onset guttate psoriasis: a long-term follow-up study. Dermatology 2023; 239: 188\u2013194.","DOI":"10.1159\/000527737"},{"key":"156523","doi-asserted-by":"crossref","unstructured":"Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 2019; 80: 1073\u20131113.","DOI":"10.1016\/j.jaad.2018.11.058"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46185\/54059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46185\/54060","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46185\/54061","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46185\/54059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:37:23Z","timestamp":1779716243000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":23,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0112","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}